ENO2 and plasma cell myeloma: Histone modification is considered an important transcriptional regulatory mechanism and is involved in the progression of multiple tumors, for example, HDAC3-mediated deacetylation leads to ENO2 activation in pancreatic cancer [37], and the HDAC4-RelB-p52 complex regulates multiple myeloma growth [38].